O.10 Cardiotoxicity of immune checkpoint inhibitors (ICI): a systematic review and meta-analysis of randomized clinical trials

Elisa Agostinetto, Daniel Eiger, Matteo Lambertini, Marcello Ceppi, Marco Bruzzone, Noam Ponde, Chris Plummer, Ahmad Hussein Awada, Martine Piccart-Gebhart, Evandro de Azambuja

O.12 Systematic review and meta-analysis of febrile neutropenia risk with TCH(P) in HER2-positive breast cancer

Hannah Van Belle, Hans Wildiers

O.19 Overall survival improvement in metastatic clear-cell renal cell carcinoma patients from 2000 to 2020

Sofie Demasure, Isabel Spriet, Philip R. Debruyne, Annouschka Laenen, Wim Wynendaele, Marcella Baldewijns, Herlinde Dumez, Paul M. Clement, Hans Wildiers, Patrick Schöffski, Eduard Rousse, Lisa Kinget, Maarten Albersen, Benoit Beuselinck

O.11 Cyclin dependent kinase inhibitors (CDK4-6i) as adjuvant treatment for patients (pts) with hormone receptor-positive (HR+)/HER2-negative (HER2-) early breast cancer (EBC): a systematic review and meta-analysis

Rafael Caparica, Elisa Agostinetto, Lucas Vian, Marco Bruzzone, Marcello Ceppi, Noam Ponde, Matteo Lambertini, Evandro de Azambuja

O.13 Colchicine as salvage for refractory pyrexia due to BRAF and MEK inhibitors: a case report

Michael Saerens, Ingeborg Hilderson, Anne Hoorens, Celine Jacobs

P16 SSB-positive renal cell carcinoma and anti-PD1-induced Sjögren's syndrome : a key to understand the link between immune-related adverse events and antitumoral activity?

Dan Truc Nguyen, Stéphane Holbrecht, Soizic Garaud

P08 Factors associated with SARS-CoV-2 infection and outcome in patients with solid tumors or hematological malignancies: a single-center study

Anouk Goudsmit, Edouard Cubilier, Anne-Pascale Meert, Philippe Aftimos, Konstantinos Stathopoulos, Chloé Spilleboudt, Angela Loizidou

P15 Impact of pandemic Covid19 on Multidisciplinary Tumor Board in Breast Cancer around the world

Sofia Cristovao Ferreira, Rita Saude Conde, Mariana Brandao, Gil Morgan, Evandro de Azambuja

P18 Retrospective analysis of the clinical presentation, treatment and outcome of angiosarcoma in a sarcoma referral center

Thomas Meyskens, Iris Timmermans, Hans Wildiers, Herlinde Dumez, Daphne Hompes, Melissa Christiaens, Raf Sciot, Annouschka Laenen, Jerry Lee, Patrick Schöffski

P17 Efficacy of palliative metronomic chemotherapy: A retrospective analysis of the 15 years experience at CHU UCL Namur site Godinne

Catherine Percy, Géraldine Rosier, Claire Barani, Fanny Collette, Laurence Faugeras, Lionel D'Hondt

P09 Developing and evaluating a participatory arts programme for cancer patients and their caregivers

Laura Tack, Tessa Lefebvre, Marlies Meersman, Hilde Vanneste, Lieselot Cool, Koen Van Eygen, Karin Stellamans, Sofie Derijcke, Philippe Vergauwe, Jos De Backer, Rebecca Chandler, Pauline Lane, Tom Boterberg, Philip R. Debruyne